News & AnalysisImmunoScape fetches $14mImmunoScape, a provider of an immunomics-based technology platform, has secured $14 million in funding.ByIris Dorbian14 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs